Lifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

PART 05: An overview of lifestyle diseases

PART 06: Market landscape

Market overview

Five forces analysis

PART 07: Pipeline landscape

PART 08: Market segmentation by therapy area

Depression

Dermatology (acne, anti-aging, and baldness)

Sexual dysfunction

Obesity

PART 09: Geographical segmentation

Lifestyle drugs market in Americas

Lifestyle drugs market in EMEA

Lifestyle drugs market in APAC

PART 10: Market drivers

Lifestyle changes

Development of novel therapeutics

Increasing demand from older population

PART 11: Impact of drivers

PART 12: Market challenges

Patent expiries

Side effects coupled with product recalls

Presence of alternative therapies and treatments

PART 13: Impact of drivers and challenges

PART 14: Market trends

Increase in M&A

Growing focus on development of drugs for new

indications

Emerging lifestyle diseases

PART 15: Vendor landscape

Competitive scenario

PART 16: Key vendor analysis

Allergan

BMS

Eli Lilly

Pfizer

Other prominent vendors

PART 17: Appendix

List of abbreviation

PART 18: Explore Technavio